GCAN
The Greater Cannabis Company, Inc. [GCAN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GCAN Stock Summary
In the News
GCAN Financial details
Company Rating
-
Market Cap
482.78K
Income
-192K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-3.1
Forward P/E
-
PEG
0.56
P/S
-
P/B
-0.94
P/C
-
P/FCF
-6.87
Quick Ratio
0.23
Current Ratio
0.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-77.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-68.19%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-96%
ROE
33%
ROC
0.27%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.0E-4-0.0015
52W High
-
52W Low
-
RSI
44.43
Rel Volume
0.07
Avg Volume
3.89M
Volume
271.19K
Perf Week
-20%
Perf Month
-14.29%
Perf Quarter
20%
Perf Half Y
-7.69%
-
-
-
-
Beta
1.564
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0006
Change
0%
Company Profile
- Volume Average 3.89M
- Market Capitalization 482.78K
- Employee 1
- CEO Mr. Aitan Zacharin
- Headquarters Baltimore,MD,US
- IPO Date 2018-09-18
-
Website
https://www.gcanrx.com 
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
